Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Acquired by Natixis Advisors L.P.

Natixis Advisors L.P. raised its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 154.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 87,681 shares of the company's stock after purchasing an additional 53,229 shares during the period. Natixis Advisors L.P. owned 0.10% of Acadia Healthcare worth $6,817,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the business. New York Life Investment Management LLC raised its holdings in shares of Acadia Healthcare by 6.5% in the fourth quarter. New York Life Investment Management LLC now owns 10,764 shares of the company's stock worth $837,000 after buying an additional 659 shares during the last quarter. Sivik Global Healthcare LLC increased its holdings in shares of Acadia Healthcare by 20.0% in the fourth quarter. Sivik Global Healthcare LLC now owns 90,000 shares of the company's stock valued at $6,998,000 after purchasing an additional 15,000 shares during the period. Retirement Systems of Alabama lifted its holdings in shares of Acadia Healthcare by 0.4% during the fourth quarter. Retirement Systems of Alabama now owns 115,496 shares of the company's stock worth $8,981,000 after purchasing an additional 409 shares during the period. Headlands Technologies LLC boosted its position in Acadia Healthcare by 422.3% in the fourth quarter. Headlands Technologies LLC now owns 1,828 shares of the company's stock valued at $142,000 after buying an additional 1,478 shares during the last quarter. Finally, Truist Financial Corp increased its holdings in Acadia Healthcare by 2.4% in the 4th quarter. Truist Financial Corp now owns 48,880 shares of the company's stock worth $3,801,000 after buying an additional 1,154 shares during the period.

Insider Buying and Selling

In related news, Director Wade D. Miquelon sold 2,203 shares of the business's stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the sale, the director now directly owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.00% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Bank of America lowered their price target on shares of Acadia Healthcare from $105.00 to $90.00 and set a "buy" rating on the stock in a report on Thursday, May 2nd. Mizuho reduced their price target on Acadia Healthcare from $84.00 to $70.00 and set a "neutral" rating for the company in a research report on Friday, May 3rd. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, March 5th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating and set a $70.00 target price for the company in a research note on Thursday, April 25th. Finally, UBS Group lifted their price objective on shares of Acadia Healthcare from $88.00 to $102.00 and gave the company a "buy" rating in a report on Wednesday, February 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $88.89.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC traded up $1.32 during midday trading on Friday, hitting $71.81. The company had a trading volume of 1,698,034 shares, compared to its average volume of 650,685. The business's 50-day simple moving average is $75.41 and its 200-day simple moving average is $77.27. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. The stock has a market cap of $6.66 billion, a price-to-earnings ratio of -503.50, a price-to-earnings-growth ratio of 1.96 and a beta of 1.31. Acadia Healthcare Company, Inc. has a twelve month low of $64.74 and a twelve month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Thursday, May 2nd. The company reported $0.84 EPS for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. The company had revenue of $768.10 million for the quarter, compared to the consensus estimate of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. Acadia Healthcare's quarterly revenue was up 9.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.75 earnings per share. On average, research analysts predict that Acadia Healthcare Company, Inc. will post 3.56 earnings per share for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.